Active Surveillance for Low-Risk Cancer—The Waiting Is the Hardest Part.

This Viewpoint describes the benefits and challenges of active surveillance as a clinical approach to monitor low-risk cancers with favorable prognoses.

Bibliographic Details
Published in:JAMA Oncology Vol. 10; no. 11; pp. 1491 - 1493
Main Authors: Haggstrom, David A., Braafladt, Signe M., Han, Paul K. J.
Format: Journal Article
Published: American Medical Association Nov2024
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=181070212&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 181070212
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23742437
        I6NW
      jtl: JAMA Oncology
      issn: 23742437
      maglogo: N
    pubinfo:
      dt: Nov2024
      vid: 10
      iid: 11
      pid: 30
      pub: American Medical Association
      place: Chicago, Illinois
    artinfo:
      ui:
        181070212
        10.1001/jamaoncol.2024.2667
        181070212
      ppf: 1491
      ppct: 2
      formats:
      tig:
        atl: Active Surveillance for Low-Risk Cancer—The Waiting Is the Hardest Part.
      aug:
        au:
          Haggstrom, David A.
          Braafladt, Signe M.
          Han, Paul K. J.
        affil: VA Health Systems Research Center for Health Information and Communication, Indianapolis VA Medical Center, Indianapolis, Indiana
      sug:
        subj:
          Disease Surveillance
          Neoplasms Risk Factors
          Anxiety Prevention and Control
          Uncertainty Prevention and Control
          Anxiety Disorders Therapy
          Psychotherapy
          Cognitive Therapy
          Acceptance and Commitment Therapy
          Patient Centered Care
          Implementation Science
          Holistic Care
      ab: This Viewpoint describes the benefits and challenges of active surveillance as a clinical approach to monitor low-risk cancers with favorable prognoses.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Unknown
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N